申请人:GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED
公开号:US20160332967A1
公开(公告)日:2016-11-17
This invention relates to crystalline forms of (R)-1-(1-(methylsulfonyl)propan-2-yl)-4-(trifluoromethyl)indoline-5-carbonitrile, a modulator of the androgen receptor, and methods for the use in treatment.
这项发明涉及(R)-1-(1-(甲磺氧基)丙基)-4-(三氟甲基)吲哚-5-羧腈的晶体形式,这是一种雄激素受体调节剂,并且涉及在治疗中的使用方法。